Trials / Completed
CompletedNCT03310983
Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 254 (actual)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to learn if participants in the ADORE study (NCT02626299), who took a DHA supplement during pregnancy, see favorable body fat in their infants from birth to 24 months, and if excessive or appropriate weight gain during pregnancy impacts this result.
Conditions
Timeline
- Start date
- 2017-11-01
- Primary completion
- 2022-08-31
- Completion
- 2022-08-31
- First posted
- 2017-10-16
- Last updated
- 2024-10-08
- Results posted
- 2024-10-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03310983. Inclusion in this directory is not an endorsement.